Galectin-1 had previously been shown to be elevated in a variety of cancers such as head and neck squamous cell carcinoma, thyroid cancer or hepatocellular carcinoma[13,14,21]. This evidence concerns the gene LGALS1 and head and neck squamous cell carcinoma.